Thrombosis sanofi introduces new clexane ranges into nigerian market

Here's a potential press release:

FOR IMMEDIATE RELEASE

Sanofi Introduces New Clexane Ranges into Nigerian Market

Lagos, Nigeria - Sanofi, a global healthcare leader, is pleased to announce the introduction of new Clexane ranges into the Nigerian market. Clexane, a low-molecular-weight heparin (LMWH), is a well-established treatment for deep vein thrombosis (DVT) and pulmonary embolism (PE).

The new Clexane ranges, which include Clexane 40mg and Clexane 60mg, offer a more convenient and flexible dosing regimen for patients, making it easier for healthcare professionals to manage their treatment. The new ranges are designed to provide a more personalized approach to treatment, allowing patients to receive the right dose of Clexane at the right time.

"We are excited to bring these new Clexane ranges to the Nigerian market," said [Name], Country Manager, Sanofi Nigeria. "Clexane has been a trusted treatment for DVT and PE for many years, and we believe that these new ranges will provide even more benefits for patients and healthcare professionals alike."

Clexane is a widely used and well-established treatment for DVT and PE, and has been shown to be effective in reducing the risk of recurrent thrombosis. The new Clexane ranges are designed to provide a more flexible dosing regimen, allowing patients to receive the right dose of Clexane at the right time.

"We are committed to providing innovative and effective treatments to patients in Nigeria," said [Name]. "The introduction of these new Clexane ranges is part of our ongoing efforts to improve patient care and outcomes in the country."

The new Clexane ranges are now available in Nigeria and can be prescribed by healthcare professionals. For more information, please contact [Name] at [Email] or [Phone number].

About Sanofi Sanofi is a global healthcare leader that discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

About Clexane Clexane is a low-molecular-weight heparin (LMWH) used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). It is available in various strengths and formulations, including injectable solutions and oral tablets.

Contact: [Name] Country Manager, Sanofi Nigeria [Email] [Phone number]